1 - IV Antibiotic Therapy (rate)Organization: CMS
Description: CPM I- Six-month rolling average rate of initiating IV antibiotic prescription therapy for newly suspected infection among adult chronic HD patients
Type: Process
2 - Frequency of hemodialysis adequacy measurementOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all pediatric (<18 years old) patients receiving in-center hemodialysis (irrespective of frequency of dialysis) with documented monthly adequacy measurements (spKt/V) or its components in the calendar month
Type: Process
3 - Method of adequacy measurementOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of pediatric (<18 years old) in-center HD patients (irrespective of frequency of dialysis) for whom delivered HD dose was measured by spKt/V as calculated using UKM or Daugirdas II during the reporting period
Type: Process
4 - Minimum target spKt/VOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all pediatric (<18 years old) in-center HD patients who have been on hemodialysis for 90 days or more and dialyzing 3 or 4 times weekly whose delivered dose of hemodialysis (calculated from the last measurements of the month using the UKM or Daugirdas II formula) was a spKt/V>= 1.2 during the reporting period
Type: Outcome
5 - Measurement of nPCROrganization: Centers for Medicare and Medicaid Services
Description: Percentage of pediatric (<18 years) in-center hemodialysis patients (irrespective of frequency of dialysis) with documented monthly nPCR measurements
Type: Process
6 - Hemoglobin process measureOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all pediatric (<18 years old) hemodialysis patients and peritoneal dialysis patients with ESRD =3 months who have monthly measures for hemoglobin. The hemoglobin value reported for the end of each reporting month (end-of-month hemoglobin) is used for the calculation
Type: Process
7 - Lower limit of hemoglobinOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of pediatric (<18 years old) hemodialysis and peritoneal dialysis patients, with ESRD >=3 months, who have a mean hemoglobin <10 g/dL for a 3 month reporting period, irrespective of ESA use. The hemoglobin value reported at the end of each reporting month (end-of-month hemoglobin) is used for the calculation.
Type: Outcome
8 - Anemia process measureOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all pediatric (<18 years old) hemodialysis and peritoneal dialysis patients prescribed an ESA at any time during the study period or who have a Hb<11.0 g/dL in at least one month of the study period for whom serum ferritin concentration and percent transferrin saturation (TSAT) are measured at least once in a three-month period
Type: Process
9 - Iron therapyOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all pediatric (<18 years old) hemodialysis and peritoneal dialysis patients with hemoglobin<11.0 g/dL and in whom simultaneous values of serum ferritin concentration was <100 ng/ml and TSAT<20% who received IV iron or were prescribed oral iron within the following three months
Type: Process
10 - Clinically Confirmed Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of clinically confirmed infection among HD patients prescribed IV antibiotics
Type: Process
11 - Clinically Confirmed Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate of clinically confirmed infection with IV antibiotic therapy among adult chronic HD patients
Type: Process
12 - Bacteremia (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate of bacteremia with IV antibiotic therapy, among adult chronic HD patients
Type: Process
13 - Bacteremia (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of bacteremia among adult chronic HD patients prescribed IV antibiotics
Type: Process
14 - VA-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate of hemodialysis vascular access-related infection with IV antibiotic therapy among adult chronic HD patients
Type: Process
15 - VA-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis access-related infection among adult chronic HD patients with a clinically confirmed infection and prescribed IV antibiotics
Type: Process
16 - VA-Related Bacteremia (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of bacteremia among adult chronic HD patients with a hemodialysis access-related infection and prescribed IV antibiotics
Type: Process
17 - Catheter-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis catheter-related infection among adult chronic HD patients with a HD access-related infection and prescribed IV antibiotics
Type: Process
18 - Graft-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis arteriovenous graft-related infection among adult chronic HD patients with a HD access-related infection and prescribed IV antibiotics
Type: Process
19 - Fistula-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis arteriovenous fistula-related infection among adult chronic HD patients with a HD access-related infection and prescribed IV antibiotics
Type: Process
20 - Catheter-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related infection with IV antibiotic therapy, among adult chronic HD patients using a catheter for hemodialysis access
Type: Process
